Tesla plans to start battery cell production in Germany by mid-2027
Tesla aims to begin producing 4680 battery cells at its Grünheide gigafactory in Germany by mid-2027. The project involves a €1 billion investment, 1,500 new hires, and a target output of 18 GWh per year. Tesla also plans to file for a second production hall in December 2026, expanding its European operations.
How this was made

The 30-second read
Why it matters
Long‑term capacity expansion may support Tesla's growth targets, but execution risk remains high.
Market read
Significant operational expansion with multi‑billion euro investment; relevant for investors tracking EV supply chain and Tesla's growth outlook.
What to watch
Regulatory approvals, construction delays, and the unproven dry‑electrode process could postpone or limit capacity rollout.
Background
Tesla's Grünheide gigafactory has been an assembly hub; this marks its first foray into in‑house cell manufacturing in Europe.
Ticker impact
Tesla announced its first European battery‑cell production line in Grünheide, targeting 18 GWh capacity and €1 bn investment by mid‑2027.
potential upside as investors price in long‑term capacity growth, though near‑term price move likely limited
Large capital commitment and new technology (dry‑electrode) could boost margins over time, but higher European costs create risk.
Market effects
Strengthens the EV battery supply chain narrative and may pressure other battery makers to consider European sites.
European industrial and labor markets could see modest job creation; local suppliers may benefit.
Adds to the global shift of battery production toward diversified locations, affecting global EV supply dynamics.
Counterpoint
Higher European production costs could erode Tesla's margin advantage, leading to a muted stock reaction.
Key entities
- companyTesla, Inc.
US‑listed EV and energy company expanding battery production in Germany.


